Tesamorelin & Ipamorelin Blend (8mg) – Premium Synergistic GH Research Peptide

Welcome to Liaocheng Yixin Company, your trusted source for premium tesamorelin ipamorelin 8mg blend for research. As a specialized peptide synthesis manufacturer operating from our facility in Shandong Province, China, we provide high-quality research compounds for the global scientific community.

This 8mg dual blend combines Tesamorelin, a stabilized GHRH analog with documented human clinical evidence, with Ipamorelin, a selective ghrelin receptor agonist known for its clean hormonal profile . Together, they target complementary receptor pathways in the hypothalamic-pituitary axis, producing amplified, pulsatile growth hormone release that exceeds the sum of either peptide alone . Our tesamorelin ipamorelin 8mg blend for research offers investigators a convenient, precisely formulated tool for endocrine signaling, metabolic research, and body composition studies. tesamorelin ipamorelin 8mg blend for research

What is the Tesamorelin & Ipamorelin Blend?

This 8mg lyophilized blend contains two research peptides that work through complementary mechanisms at the hypothalamic-pituitary axis :

Tesamorelin is a synthetic 44-amino-acid peptide analogue of growth hormone-releasing hormone (GHRH) with an N-terminal modification that enhances stability and resistance to enzymatic degradation . It is the only GHRH analog with FDA approval and Phase 3 human trial data demonstrating 15.2% visceral adipose tissue reduction and 81% IGF-1 elevation . Ipamorelin is a pentapeptide ghrelin mimetic known for its highly selective GH release with minimal stimulation of cortisol or prolactin .

Mechanism of Action in Research

The blend combines two distinct pathways to produce synergistic GH release :

GHRH Receptor Pathway (Tesamorelin)

Tesamorelin binds the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, activating Gs-coupled adenylyl cyclase signaling . This elevates intracellular cAMP, activates protein kinase A (PKA), and drives GH gene transcription and granule exocytosis. The trans-3-hexenoic acid modification confers resistance to DPP-IV degradation, extending the half-life to approximately 26-60 minutes compared to ~7 minutes for native GHRH .tesamorelin ipamorelin 8mg blend for research

Ghrelin Receptor Pathway (Ipamorelin)

Ipamorelin activates GHS-R1a, a class A GPCR that couples primarily through Gq/11-alpha . This activates phospholipase C (PLC), generating inositol trisphosphate (IP3) and diacylglycerol (DAG), which mobilize intracellular calcium stores and activate protein kinase C (PKC). The calcium surge triggers immediate exocytosis of pre-formed GH vesicles .

Synergistic Amplification

The combination of GHRH-pathway (cAMP/PKA) and ghrelin-pathway (PLC/PKC/Ca2+) activation produces synergistic GH release that substantially exceeds the sum of individual peptide effects . This dual-receptor activation preserves the natural pulsatile pattern of GH secretion while amplifying pulse amplitude .

Ipamorelin Selectivity

The defining feature of Ipamorelin is its selectivity. Raun et al. (1998) demonstrated that Ipamorelin releases GH without significantly affecting ACTH, cortisol, or prolactin levels . This makes Ipamorelin the preferred pairing partner for researchers requiring a “clean” GH response.

Scientific Research Applications

Metabolic and Visceral Fat Research

Tesamorelin has the strongest evidence base among the two components. In large randomized controlled trials of HIV patients with lipodystrophy, tesamorelin demonstrated 15.2% reductions in visceral adipose tissue (VAT) and improvements in liver enzymes . Research has also shown tesamorelin decreases muscle fat infiltration (myosteatosis) and increases muscle density . This makes the blend valuable for studying fat metabolism, liver health, and muscle quality in research models.

Body Composition Studies

The combined GH-axis stimulation from both peptides supports investigations into:

• Lean mass preservation and muscle protein synthesis 

• Visceral adipose tissue reduction and lipid mobilization 

• Recovery and tissue repair mechanisms 

• tesamorelin ipamorelin 8mg blend for research

Endocrine and Receptor Signaling Research

The combination allows researchers to investigate:

• GHRH vs. ghrelin pathway interactions 

• Pulsatile vs. sustained GH exposure mechanisms 

• Receptor desensitization and recovery kinetics 

• tesamorelin ipamorelin 8mg blend for research

Bone and Connective Tissue Research

Ipamorelin has demonstrated positive effects on bone health in murine studies, with potential stimulation of bone formation and enhancement of bone mass . In vitro research has also indicated effects on collagen synthesis, making the blend relevant for connective tissue studies .

Sleep and Recovery Research

The blend is often dosed at bedtime to align with the body’s natural nocturnal GH surge . Research suggests amplified GH signaling may support deeper slow-wave sleep and enhanced recovery .tesamorelin ipamorelin 8mg blend for research

Important Research Considerations

Evidence Base

• Tesamorelin has FDA approval for HIV-associated lipodystrophy and documented Phase 3 data 

• Ipamorelin has foundational animal data (Raun et al., 1998) and limited human trial data 

• The blend itself has not been tested in a dedicated human trial; synergy is extrapolated from classtesamorelin ipamorelin 8mg blend for research-level evidence 

Regulatory Status

• Tesamorelin is FDA-approved only for HIV-associated lipodystrophy 

• Both peptides are prohibited at all times under WADA rules (Section S2) 

• The blend is not FDA-approved and is sold for research use only 

• tesamorelin ipamorelin 8mg blend for research

Why Choose Liaocheng Yixin Company?

When sourcing tesamorelin ipamorelin 8mg blend for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Our blend meets ≥99% purity standards. Certificates of Analysis are available upon request.

Research-Grade Specifications

• Purity: ≥99% verified by HPLC

• Components: Tesamorelin + Ipamorelin (8mg total)

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed, desiccated container, protected from light and moisture 

• Form: Lyophilized powder for research use

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

6. tesamorelin ipamorelin 8mg blend for research

: How does the Tesamorelin & Ipamorelin blend work in research?

A: Tesamorelin activates the GHRH receptor on pituitary somatotrophs through the cAMP/PKA pathway, while Ipamorelin engages the ghrelin receptor (GHS-R1a) through calcium mobilization . This dual-receptor activation produces synergistic GH output that substantially exceeds the additive sum of either peptide alone .

: What distinguishes this blend from other GHRH/GHRP combinations?

A: Tesamorelin carries the strongest human-trial pedigree among GHRH analogs due to its FDA approval and Phase 3 data . Ipamorelin provides a clean GH release profile with minimal cortisol or prolactin elevation . This combination offers both strong evidence (on the GHRH side) and receptor selectivity (on the GHRP side).

: What are the key research applications for this blend?

A: This blend is used in metabolic research (visceral fat, muscle density studies), body composition studies, endocrine and receptor signaling research, bone and connective tissue studies, and sleep/recovery investigations .

: What purity level can I expect?

A: All batches are tested to ensure ≥99% purity by HPLC analysis. Certificates of Analysis are available upon request.

: Is this product for human use?

A: No. This blend is manufactured strictly for research use only (RUO). It is not intended for human consumption or clinical applications .

When you need premium tesamorelin ipamorelin 8mg blend for research for your endocrine, metabolic, or receptor pharmacology studies, choose a manufacturer that prioritizes quality, ttesamorelin ipamorelin 8mg blend for researchransparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust.